Company
The BC Bud Corp
Headquarters: Vancouver, BC, Canada
CEO: Mr. Brayden R. Sutton
The BC Bud Corp Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
The BC Bud Corporation produces and sells cannabis products. It focuses on developing flowers for use in concentrates, consumables, and recreational activities using its proprietary genetics; edibles, initially through CannaBeans, a chocolate covered coffee bean with cannabis; beverages, including a non-alcoholic beer and future research and development into infused waters and other beverage classes; concentrates through the Solventless Solutions brand, which would include vaporizer cartridges and other concentrates; and an apparel line. The company is based in Vancouver, Canada.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
The BC Bud Corp has the following listings and related stock indices.
Stock: CSE: BCBC wb_incandescent